: Phenotyping of Y. pestisinfected cells (a) Graph represents the total numbers of cells within DLNs determined by flow cytometry to be single positive (SP) and double positive (DP) for markers CD11b and CD11c, after gating on cells staining positive for YP-OFP. For each group, n≥3. (b)Y. pestis expressing OFP were conjugated to magnetic particles following an established protocol 1 and used to infect the footpads of mice by injection of 1x10 5 CFU subcutaneously. After 24h, DLNs were isolated, processed to form single cell suspensions, and a magnet was used extract the bacteria within the LN. After washing, the fraction remaining was spun onto slides, fixed, and stained for actin (green) and the surface monocyte/macrophage marker, CD11b (blue). Many intracellular bacteria could be observed within cells that had surface staining for CD11b, and surrounded by actin. (c) Gating strategy used to phenotype cells in Figure 2b . (d) Gating strategy used to phenotype cells in Figure  2c- 
Supplemental Methods: Microscopy
For H&E staining, tissues were either frozen sectioned and fixed or prepared by paraffin imbedding, followed by sectioning, deparaffinizing and rehydration in water. Standard H&E protocols were then used, staining first with hematoxilyn, then washing with water, counterstaining eosin, followed by washing, dehydration and mounting.
For frozen sectioning, isolated tissues were flash frozen in OCT (TissueTek), then cryostat sectioned (10 µm) and fixed on slides with acetone for 15 minutes at 4°C. To obtain the image in Figure 4c , mice were euthanized and perfused with 4% paraformaldehyde to fix tissues in situ. Skin was removed from legs, which were subjected to demineralization according to a published protocol 2 . Briefly, the legs were placed into decalcification buffer (10% EDTA in 0.1M Tris buffer, pH 6.95) and kept in the dark at 4°C for 2 weeks.
The buffer was changed every 3-4 days. Demineralized hind legs were then embedded and frozen in OCT for sectioning. For all immuno-staining, tissue sections were rehydrated in PBS containing 1% BSA for 20 minutes, followed by overnight staining with primary antibodies, as indicated in the figure legends: antiCD11b, anti-CD11c, anti-CD31-biotin (BD Biosciences), anti-F4/80-PE (eBiosciences), anti-Lyve-1. The following secondary antibodies were used: biotinylated anti-hamster (Pharmingen), followed by streptavadin-APC (BD Biosciences) or anti-goat-FITC (Jackson ImmunoResearch).
For TEM, LN tissue was fixed in 4% glutaraldehyde. The samples were treated with 1 % osmium tetroxide (Electron Microscopy Sciences) before dehydration using increasing concentrations of ethanol and embedding in resin. Samples were then sectioned (50-70 nm) and stained with 2 % uranyl acetate/lead citrate (TAAB Laboratories) before viewing using a JM1010 electron microscope (JEOL). Sample processing was performed by the National University of Singapore electron microscopy core facility.
Real time PCR
To quantify chemokine mRNA, we homogenized individual lymph nodes or footpads using ceramic beads for 2 cycles of 20 seconds each by automatic homogenizer, followed by RNA isolation using the 
Flow Cytometry
Tissues were isolated from mice at the time points indicated and minced in RPMI containing 10% FBS and 100U/ml of Collagenase A (Sigma). Single cell suspensions were produced by straining the disrupted lymph nodes through a 70µM cell straining filter (BD Biosciences). Total cells were calculated after counting using a hemacytometer. To stain for DCs and monocytes, we used the following antibodies: anti-CD11b-APC anti-CD11c-FITC (BD Biosciences). Either cells from un-infected controls were individually stained for CD11b or CD11c, or YP-OFP-infected, unstained DLN cells were used as compensation controls. Additional flow cytometry was performed for S1P receptors using antibodies against S1P 1 or S1P 3 (R&D Systems)
followed by staining with anti-rat or anti-rabbit FITC-conjugated secondary antibodies (Jackson ImmunoResearch). Antibodies against CX3CR1 were obtained from Fisher Scientific and used with an AlexFluor647-conjugated anti-rabbit secondary antibody (Jackson ImmunoResearch). Additional cell phenotyping of multiple myeloid subsets was performed by staining LN cells in PBS with 3% fetal bovine serum, 10mM EDTA, 5% normal mouse serum, 5% normal rat serum and 1% FC Receptor Block 
Ex vivo gentamicin protection assay
To quantify the extracellular versus intracellular Y. pestis populations within LNs, an ex vivo gentamicin protection assay was performed. Gentamicin was chosen as the antibiotic for this experiment because Y. pestis is highly susceptible to it 3,4 . DLNs and ILNs were isolated and incubated in antibiotic-free RPMI with 10% FBS and 100μg/mL collagenase at 37°C for 30min. Single cell suspensions were then prepared. This was divided into two equal aliquots, one treated with 2μg/mL gentamicin (pre-determined to be 100% bactericidal) and the other with control (RPMI media) to kill extracellular Y. pestis for 30 min at 37°C. After washing with PBS, samples were resuspended in 100μL dH 2 0 to lyse cells and plated on BHI agar. CFUs were enumerated after 48h growth at room temperature. The fraction of intracellular bacteria was then determined as a percentage of the total by calculation.
For magnetic isolation of Y. pestis-containing cells, Y. pestis expressing OFP was conjugated to magnetic beads precisely following an established protocol 1 . 1x10 5 labeled bacteria were injected into the footpads of mice. After 24h, DLNs were harvested and processed to produce a single cell suspension, as previously described. Isolation of bacteria was performed using a magnet, again following the methods provided by Lonnbro et al. Isolated bacteria were resuspended in PBS and applied to slides by cytospinning. Slides were then fixed in acetone, prior to staining for actin (Alexafluor488-conjugated phalloidin, Molecular Probes) and CD11b, followed by visualization by confocal microscopy. 
